LHC
BIO icon

Lodge Hill Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Lodge Hill Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-154,500
Closed -$28.2M – 36
2016
Q4 		$28.2M Buy
154,500
+23,800
+18% +$4.06M 3.59% 14
2016
Q3 		$21.4M Buy
+130,700
New +$19.8M 2.62% 17

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Lodge Hill Capital's BIO Position: Q1 2017 in Review

Lodge Hill Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2017, closing a stake of 154,500 shares — an estimated $28.2M sold.

Lodge Hill Capital first reported a position in BIO in Q3 2016 and held it in 2 quarters. The position peaked at $28.2M in Q4 2016. 274 funds tracked by Wall St. Rank hold BIO as of Q1 2017.

  • Lodge Hill Capital reported no remaining Bio-Rad Laboratories Class A position as of Q1 2017 after selling out during the quarter.
  • Lodge Hill Capital sold 154,500 Bio-Rad Laboratories Class A shares in Q1 2017, an estimated $28.2M.
  • Lodge Hill Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and held it in 2 quarters.
  • Lodge Hill Capital's Bio-Rad Laboratories Class A position peaked at $28.2M in Q4 2016.
  • 274 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2017.

Based on Lodge Hill Capital's 13F filing for Q1 2017, filed 12 May 2017.